Tuesday, December 4, 2018

Genetically engineered immune cells show promise for fighting relapsed blood cancer

Researchers are presenting preliminary results from a clinical study of an investigational cellular immunotherapy for Hodgkin lymphoma and non-Hodgkin lymphoma expressing the CD30 protein marker.

from Top Health News -- ScienceDaily https://ift.tt/2RxWVXo
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

A tiny ocean worm just revealed a big secret about how eyes evolve

Scientists found that adult bristleworm eyes grow continuously thanks to a rim of neural stem cells similar to those in vertebrate eyes. Thi...